To determine if the detection of CCT2 in breast cancer cells could be extended to other cancer cells, we spiked CRL5853 and CRL5903 SCLC cell lines into blood and performed CCT2 staining in the CSS platform. This evidence concerns the gene CCT2 and breast cancer.